The Cancer Genome Atlas Program identified TP53 mutations and the loss of its protein’s pathway to be one of its key characteristics; 71% of their CIN tumors had a TP53 mutation (Cancer Genome Atlas Research 2014). This evidence concerns the gene TP53 and cancer.